Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeres Power Regulatory News (CWR)

Share Price Information for Ceres Power (CWR)

Share Price is delayed by 15 minutes
Get Live Data
609.50    -40.50 (-6.23%)
Bid:
606.50
Ask:
614.50
Spread: 8.00 (1.319%)
Market Cap: £1.19b
CWR Live PriceLast checked at - London Stock Exchange

Intraday Ceres Power Share Chart

Holding(s) in Company

4 Apr 2013 09:50

RNS Number : 5611B
Ceres Power Holdings plc
04 April 2013
Β 

ο»Ώ

Β 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Ceres Power Holdings plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

X

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

IP Group plc

4. Full name of shareholder(s) Β (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

2 April 2013

6. Date on which issuer notified:

3 April 2013

7. Threshold(s) that is/are crossed orreached: vi, vii

24% reached

Β 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary 1p

107,500,000

107,500,000

132,500,000

132,500,000

24.7%

GB00B0351429

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

Β 

% of voting rights xix, xx

Β 

Β 

Β 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

132,500,000

24.7%

Β 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Direct interests:

Β 

IP2IPO Limited: 132,500,000

Β 

IP2IPO Limited is a 100%-owned subsidiary of IP Group plc.

Β 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

Based on 536,563,285 Ordinary Shares in issue

14. Contact name:

Greg Smith

15. Contact telephone number:

0845 074 2929

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLUSOWROKASRRR
Date   Source Headline
6th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 202511:30 amRNSHolding(s) in Company
2nd Oct 20257:01 amRNSHolding(s) in Company
2nd Oct 20257:00 amRNSHolding(s) in Company
30th Sep 202510:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSNotice of Interim Results
29th Aug 202510:00 amRNSTotal Voting Rights
31st Jul 202510:00 amRNSTotal Voting Rights
28th Jul 20257:00 amRNS-RDoosan Fuel Cell and Ceres joint announcement
10th Jul 20254:05 pmRNSHolding(s) in Company
9th Jul 20255:25 pmRNSHolding(s) in Company
7th Jul 20254:46 pmRNSSALE OF ORDINARY SHARES IN CERES POWER
7th Jul 202510:00 amRNSBlock listing Interim Review
30th Jun 202510:00 amRNSTotal Voting Rights
27th Jun 202511:00 amRNSGrant of Long Term Incentive Plan (“LTIP”) Awards
16th Jun 20252:00 pmRNSGrant of Share Options under the Sharesave Scheme
30th May 202510:00 amRNSTotal Voting Rights
20th May 20257:00 amRNS-RFirst hydrogen production at MW-scale demonstrator
15th May 20253:15 pmRNSResult of AGM
30th Apr 20257:00 amRNSTotal Voting Rights
28th Apr 202511:30 amRNSDirector/PDMR Shareholding
11th Apr 202510:00 amRNSNotice of AGM & Publication of Annual Report
31st Mar 20257:00 amRNSTotal Voting Rights
21st Mar 20257:00 amRNSFinal results for the year ended 31 December 2024
11th Mar 20257:28 amRNSNotice of results and revised trading update
28th Feb 20257:00 amRNSTotal Voting Rights
20th Feb 202511:45 amRNSDirectorate Change
20th Feb 20257:00 amRNSStatement regarding Robert Bosch GmbH
31st Jan 20257:00 amRNSTotal Voting Rights
30th Jan 202510:30 amRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSTrading update for the year ended 31 December 2024
28th Jan 20254:55 pmRNSHolding(s) in Company
14th Jan 202510:00 amRNSBlock Listing Application
7th Jan 20257:00 amRNSBlock listing Interim Review
31st Dec 20247:00 amRNSTotal Voting Rights
29th Nov 20247:00 amRNSTotal Voting Rights
28th Nov 20243:30 pmRNSNotifications of transactions by PDMRs
31st Oct 20247:00 amRNSTotal Voting Rights
9th Oct 20246:00 pmRNSWitan Investment Trust
7th Oct 20242:12 pmRNSGrant of Long Term Incentive Plan Awards
3rd Oct 20243:36 pmRNSNotifications of transactions by PDMRs
30th Sep 20247:00 amRNSTotal Voting Rights
27th Sep 20247:00 amRNSInterim results for the six months ended 30 June
12th Sep 20249:58 amRNSCeres signs Thermax as SOEC system partner
6th Sep 20247:00 amRNSBoard change: Appointment of Stuart Paynter as CFO
4th Sep 20247:00 amRNSNotice of Results
30th Aug 20247:00 amRNSTotal Voting Rights
6th Aug 20247:05 amRNSCeres and Denso partnership investor meeting today
6th Aug 20247:00 amRNSCeres confirms Denso as the latest licence partner

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.